Crispr Therapeutics shares owned by Axxcess Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Axxcess Wealth Management
from 13F filings
Historical chart of Axxcess Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Axxcess Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Axxcess Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $670k | 14k | 47.57 |
| 2025-12-31 | $683k | 13k | 52.44 |
| 2025-09-30 | $794k | 12k | 64.81 |
| 2025-06-30 | $562k | 12k | 48.64 |
| 2025-03-31 | $351k | 10k | 34.03 |
| 2024-12-31 | $390k | 9.9k | 39.36 |
| 2024-09-30 | $483k | 10k | 46.98 |
| 2024-06-30 | $537k | 9.9k | 54.01 |
| 2024-03-31 | $678k | 9.9k | 68.16 |
| 2023-12-31 | $566k | 9.0k | 62.60 |
| 2023-09-30 | $353k | 7.8k | 45.39 |
| 2023-06-30 | $500k | 8.9k | 56.14 |
| 2023-03-31 | $447k | 9.9k | 45.23 |
| 2022-12-31 | $379k | 9.3k | 40.60 |
| 2022-09-30 | $794k | 12k | 65.36 |
| 2022-06-30 | $856k | 14k | 60.80 |
| 2022-03-31 | $811k | 13k | 62.78 |
| 2021-12-31 | $1.2M | 16k | 75.75 |